Five School of Pharmacy researchers in first cohort of Chan Zuckerberg Biohub Investigators

Fifteen UC San Francisco faculty members have been named to the first cohort of Chan Zuckerberg Biohub Investigators, including five from the School of Pharmacy.

UCSF School of Pharmacy’s CZ Biohub Investigators are (left to right): Adam Abate, PhD; Zev Gartner, PhD; Bo Huang, PhD; Tanja Kortemme, PhD; James Wells, PhD.

The CZ Biohub is an independent nonprofit research organization formed as a collaboration between UCSF, UC Berkeley and Stanford University with the goal of inventing new tools to accelerate transformative advances in the life sciences. CZ Biohub is funded by a $600 million commitment from Facebook CEO and founder Mark Zuckerberg and pediatrician Priscilla Chan, and it is the first philanthropic science investment made by the Chan Zuckerberg Initiative, which is dedicated to advancing human potential and promoting equality.

The first cohort of CZ Biohub Investigators includes 47 faculty members from the three universities. The group includes both highly accomplished senior professors as well as up-and-coming young faculty.

UCSF has nine senior investigators and six junior investigators in the cohort; the senior investigators include these five faculty members from the School of Pharmacy:

1. Adam Abate, PhD, Department of Bioengineering and Therapeutic Sciences
2. Zev Gartner, PhD, Department of Pharmaceutical Chemistry
3. Bo Huang, PhD, Department of Pharmaceutical Chemistry
4. Tanja Kortemme, PhD, Department of Bioengineering and Therapeutic Sciences
5. James Wells, PhD, Department of Pharmaceutical Chemistry

Full story

15 UCSF Researchers Named to First Cohort of Chan Zuckerberg Biohub Investigators